Haemophilus influenzae infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 40: | Line 40: | ||
#http://www.cdc.gov/ncidod/dbmd/diseaseinfo/histoplasmosis_g.htm | #http://www.cdc.gov/ncidod/dbmd/diseaseinfo/histoplasmosis_g.htm | ||
#http://wwwn.cdc.gov/travel/yellowBookCh4-FluMeningitis.aspx | #http://wwwn.cdc.gov/travel/yellowBookCh4-FluMeningitis.aspx | ||
[[Category:Infectious Disease Project]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Revision as of 20:18, 10 August 2015
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Haemophilus influenzae.
For patient information, click here
|
Haemophilus influenzae infection Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hib disease
Overview
Pathophysiology
Causes
Differentiating Haemophilus influenzae serotype B infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of therapy | Future or Investigational Therapies